Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-21-000335
Filing Date
2021-01-20
Accepted
2021-01-20 11:11:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 INMED PHARMACEUTICALS INC. p21-0139sc13ga.htm SC 13G/A 75413
  Complete submission text file 0000902664-21-000335.txt   76906
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1205 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1205 NEW YORK NY 10020 212-608-3300
Empery Asset Management, LP (Filed by) CIK: 0001469336 (see all company filings)

EIN.: 262107121 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Subject) CIK: 0001728328 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: SC 13G/A | Act: 34 | File No.: 005-91842 | Film No.: 21537755
SIC: 2834 Pharmaceutical Preparations